Sorted By:

Relevance


3 Tiers, 4 Tiers, 5 Tiers and More – A look at tiering in health insurance exchange plans

PhRMA  |  Blog Post

  While having plans submit data is meant to increase transparency for consumers and make it easier to compare cost sharing across plans, it is actually misleading many of them about how what their out-of-pocket costs will be.
http://catalyst.phrma.org/3-tiers-4-tiers-5-tiers-and-more-a-look-at-tiering-in-health-insurance-exchange-plans

Medicare Monday: New Research on How Successfully Managing Diabetes Helps Patients and Part D Save

PhRMA  |  Blog Post

Improving medication adherence through programs like medication therapy management and other initiatives is important not only to ensure patient health, but also to help reduce costs in the health care system overall.
http://catalyst.phrma.org/medicaremonday-new-research-on-how-successfully-managing-diabetes-helps-patients-and-part-d-save

PhRMA and Lupus Foundation of America Report More Than 300 Medicines in Development for Autoimmune Diseases

PhRMA  |  Press Release

 About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org

Part D Implementation Improved Enrollees’ Access to Medicine and Reduced Out-of-Pocket Costs

Chartpack  |  From Our Network

Peer-reviewed and academic literature confirms Medicare Part D substantially reduced out-of-pocket costs and increased access to medicines for seniors.
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/part-d-implementation-improved-enrollees-access-to-medicine-and-reduced-out-of-pocket-costs

Burden on Patients: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines

PhRMA  |  Blog Post

These treatments, however, are covered at just 58 percent and 17 percent, respectively on exchange plans.
http://catalyst.phrma.org/burden-on-patients-mental-health-disorders-can-affect-anyone-and-health-insurance-exchanges-must-pro

New Report: Nearly 4.5 Million U.S. Jobs and $1.2 Trillion Economic Output Supported by Biopharmaceutical Sector in 2014

PhRMA  |  Press Release

Today we’re helping nations, states, regions, universities, and industries blueprint their future and translate knowledge into prosperity.
https://www.phrma.org/press-release/new-report-nearly-4-5-million-u-s-jobs-and-1-2-trillion-economic-output-supported-by-biopharmaceutical-sector-in-2014

PhRMA Statement of Support for Introduction of the Customs Facilitation and Trade Enforcement Reauthorization Act of 2009

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-of-support-for-introduction-of-the-customs-facilitation-and-trade-enforcement-reauthorization-act-of-2009

Rheumatoid Arthritis Quality: Current and Future Status

PhRMA  |  Fact Sheet

This ongoing shift has led payers to use quality measures to assess health outcomes and incentivize high-value care.
https://www.phrma.org

Director – Policy & Research

PhRMA  |  PhRMA Career

This position is no longer available. Please check our careers page for more opportunities. ...
https://www.phrma.org/careers/director-policy-and-research

Policy Solutions to Foster Innovation and Access to Personalized Medicines: Discovery

Chartpack  |  From Our Network

Policies must ensure an environment that provides strong intellectual property protections, advances the science, provides adequate research funding, and encourages STEM training.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/advancing-policies-to-foster-innovation-sustaining-advances-in-personalized-medicine/policy-solutions-to-foster-innovation-and-access-to-personalized-medicines-discovery

IP protections found to be critical to life-science innovation and investment

PhRMA  |  Blog Post

Established, long-term exclusivity periods foster invention and provide drug creators the confidence they need to take risks and invest in the future.
http://catalyst.phrma.org/ip-protections-found-to-be-critical-to-life-science-innovation-and-investment

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

As we reflect on World Cancer Day, we are energized by the progress we have made against cancer and have tremendous hope for the future.
http://catalyst.phrma.org/world-cancer-day-reflecting-on-progress-and-hope-for-the-future-in-cancer-treatment

New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy

PhRMA  |  Press Release

Front Range Cancer Specialists, Fort Collins and Loveland.
https://www.phrma.org/press-release/new-report-shows-colorado-clinical-trials-benefit-state-s-health-and-economy

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

PhRMA  |  Blog Post

Learn more about the CTI and how this innovative approach translates into real progress and hope for patients.
http://catalyst.phrma.org/collaboration-for-cures-teaming-up-to-advance-science-and-save-lives

Transparency and confidentiality in FDA’s proposed quality metrics proposal is key

PhRMA  |  Blog Post

A phased-in approach to the quality metrics program would help to balance the potential benefits with any unnecessary burden for both the Agency and industry so that we can both continue to meet our shared goal of protecting and promoting patient health.
http://catalyst.phrma.org/transparency-and-confidentiality-in-fdas-proposed-quality-metrics-proposal-is-key

Together - Type 2 Diabetes

PhRMA  |  Video

That’s why patients like Angel and researchers like Laura will be tenacious in their fight to end this disease once and for all.
https://www.phrma.org

A Comparative Analysis of the Role and Impact of Health Technology Assessment

PhRMA  |  Report

However, it is also possible that a poorly designed or managed HTA process runs the risk of denying patients appropriate access to medical technologies, inefficiently allocating resources, constraining clinical freedom and sending distorted signals to medical technology providers.
https://www.phrma.org/report/a-comparative-analysis-of-the-role-and-impact-of-health-technology-assessment

Biopharmaceutical Research Companies Play a Pivotal Role in Drug Discovery and Development

Chartpack  |  From Our Network

The private sector is making the largest R&D contributions in translating basic research findings into therapeutic advances for patients. ...
http://chartpack.phrma.org/2016-perspective/chapter-2/biopharmaceutical-research-companies-play-a-pivotal-role-in-drug-discovery-and-development

In Part B, Beneficiaries Save Through Price Negotiations Between Manufacturers and Providers

Chartpack  |  From Our Network

Discounts and rebates negotiated by doctors, hospitals, health systems, and other purchasers are factored into the Medicare Part B payment rate and can lead to lower costs to the Medicare program and beneficiaries. 
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/in-part-b-beneficiaries-save-through-price-negotiations-between-manufacturers-and-providers

Improved Adherence for Parkinson’s Patients Linked With Reduced Health Care Utilization and Expenditures

Chartpack  |  From Our Network

Higher adherence to antiparkinson therapy and longer duration of use were associated with lower health care utilization and expenditures for Part D enrollees with Parkinson’s disease. 
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/improved-adherence-for-parkinson-s-patients-linked-with-reduced-health-care-utilization-and-expenditures

New Report: Decades of Drug Research Failures and Successes Transform Hepatitis C from Incurable to Curable Disease

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/new-report-decades-of-drug-research-failures-and-successes-transform-hepatitis-c-from-incurable-to-curable-disease

Earth Day 2015: Green Initiatives are Good for Business and the Environment

PhRMA  |  Blog Post

Biopharmaceutical companies’ commitment to finding new ways to reduce waste, conserve energy, and adopt greener alternatives in the R&D and manufacturing processes isn’t just good for business it’s good for the environment.
http://catalyst.phrma.org/earth-day-2015-green-initiatives-are-good-for-business-and-the-environment

GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure

From Hope To Cures  |  From Our Network

ViiV has significant clinical expertise and will play an advisory role to the HIV Cure center and Qura Therapeutics.
http://www.fromhopetocures.org/gsk-and-unc-chapel-hill-announce-novel-partnership-to-accelerate-search-for-hiv-cure

More Than 240 Innovative Medicines in Development For Leukemia, Lymphoma and Other Blood Cancers

PhRMA  |  Press Release

### The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/more-than-240-innovative-medicines-in-development-for-leukemia-lymphoma-and-other-blood-cancers

Partnership for Prescription Assistance Celebrates Five Year Anniversary and Launch of ‘PPA 2.0’

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/partnership-for-prescription-assistance-celebrates-five-year-anniversary-and-launch-of-ppa-2-0

You have reviewed the first 375 results out of 2506. Each page contains 25 results. You're on page 15.

prev 13 14 15 16 17 18 next